DYM

1. DYM lowers the risk of muscle weakness in silico (OR < 1, p < 0.05).

   “higher expression of DYM and TGFA reduced the risk of muscle weakness (OR < 1, p < 0.05)”

   In silico

   Identifying Susceptibility Genes and Shared Genetic Architecture for Longevity and Muscle Weakness

   Journal of cachexia, sarcopenia and muscle·27 Jan 2026

More on Muscle weakness